Moderna completes enrollment in its large COVID-19 vaccine study
Company says, over 25,650 participants have so far received their second shot of the vaccine candidate
Advertisement
London, October 22
Moderna Inc said on Thursday it had completed enrolling 30,000 participants in a late-stage study testing its experimental coronavirus vaccine.
Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.
Advertisement
Moderna said its study includes more than 11,000 participants from minority communities in the US, representing 37 per cent of the study population. Reuters
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Combo
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement